Official UK procurement notice
Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services
Authority: University Hospitals of Derby and Burton NHS Foundation Trust (Central government)
Re-procurement plannedFramework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services · tender expected
What is being bought
Published requirement descriptionThe current contract is due to expire on 30 June 2026. To maintain continuity of patient care and ensure uninterrupted product and service delivery, EMPC will extend the existing agreements with current Awarded Suppliers for a further 12 months from 1st July 2026 until 30th June 2027.
This is following the Transparency Notice published on the Find a Tender portal on 26th January 2026.
Notice identifier: 2026/S 000-006485.
Full justification has been provided in the Transparency Notice.
Pre-market Engagement Notice published on 12th May 1015
Notice identifier: 2025/S 000-020394
EMPC are in the process of undertaking Spend Controls approval and new Procurement Timescales will be communicated as soon as possible.
This extension has been awarded to:
Bath ASU
Baxter Healthcare Limited
ITH Pharma Ltd
How this framework works
From the published notice- Type
- Closed framework
- Supplier levy on call-offs (max %)
- N.A
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 26 Jan 2026, 10:31 GMT
- Last source update
- 7 Apr 2026, 12:38 BST
- Authority reference
D100 - C358943- FTS notice number
2026/S 000-031428- Latest notice
- Contract award notice (UK6)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-060e0fFind a Tender
- Why no open competition
- Switching Direct Award
- Published justification
The estimated revised spend for EMPC for this new Contract value now exceeds the Cabinet Office Spend Control Threshold of £20 million for a two-year framework period. This is due to the increase requirements for additional molecules across our member Trusts.
Under Cabinet Office Spend Control requirements, EMPC are required to submit a business case for approval prior to publishing the new tender.
The current contract is due to expire on 30 June 2026. To maintain continuity of patient care and ensure uninterrupted product and service delivery, EMPC will extend the existing agreements with current Awarded Suppliers beyond this date. New Procurement timescales will be communicated to the market as soon as possible.
It is anticipated the new Tender will be published in the summer of 2026 if spend control approval is given.
A UK 06 Contract Award and a UK 07 Contract Details Notice will be published on the Find a Tender portal.
- Risks
No risk to extending as Suppliers are known to the Trusts.
The risk is having no continuity of essential contract performance management and may mean that Trusts may have to find alternative sources of supply outside of Contract.
How it was run
Official notice- Appointment period ends
- —
- Supplier levy on call-offs (max %)
- call-off levy · N.A
Timeline
7 Apr 2026 → 16 Apr 2026 · 2 dates- Notice published204 days ago7 Apr 2026, 12:38 BST
- Standstill ends195 days ago16 Apr 2026, 23:59 BST
Notice history
3 events · 2 releases on Find a Tender · since 26 Jan 2026- Transparency notice published26 Jan 2026, 10:31 GMTUK5
- Contract award notice published7 Apr 2026, 12:38 BSTUK6
- Contract signature expected8 Jun 2026, 23:59 BSTscheduled
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Baxter Healthcare Ltd, ITH Pharma Limited, Qualasept Ltd t/a Bath ASUContract Extension following Transparency1 Jul 2026 – 30 Jun 2027 · up to 30 Jun 2028Extensions: Dependent on outcome of OBC and if a FBC is required for Spend Controls | £9,000,000 | 1 Apr 2026standstill to 16 Apr 2026 | Standstill |
Contracting authority & participating public bodies
Framework contractors & participating bidders
3 commercial parties on the notice- Bath ASUFramework contractor
- Baxter Healthcare LtdFramework contractor
- ITH Pharma LtdFramework contractor
Official documents & specifications (2)
Official links; attachments are not copiedNotices published for this procedure
- Contract award notice Contract award notice on Find a Tender
- Transparency notice Transparency notice on Find a Tender